HIGH-PERFORMANCE liquid chromatography (HPLC) is a sensitive and precise method for detecting hemoglobin abnormalities. 6 ' 7 For routine diagnostic pur-poses, hemoglobin electrophoresis using cellulose acetate at an alkaline pH and citrate agar at an acid pH have been used in most pathology laboratories. If confirmation was required, it could be achieved by the use of low-pressure, macro-column chromatography, a labor-intensive procedure. 5 Low-pressure chromatography, using a weak cation exchange material such as CM-cellulose or an anion exchange material such as DEAE-cellulose, takes two to three days for a complete separation of hemoglobin variants. Microchromatographic technics decrease the chromatographic time but sacrifice resolution. Isoelectric focusing also has been used to define hemoglobin variants and has provided excellent resolution. 1 However, the hemoglobin is not easily quantitated by this technic nor is
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Report of Three Cases it typically performed by a routine pathology department, and, for these reasons, it has been confined primarily to research laboratories.
Both anion and cation exchange packing materials have been prepared for HPLC application. Anion exchange chromatography of hemoglobins using HPLC has been able to resolve some of the major hemoglobins, 6 with improved separation over electrophoresis of HbA and HbF in the neonate. 2 However, it lacks the ability to resolve the rare hemoglobin variants. A cation exchanger developed by Wilson and associates 10 provided higher resolution in comparison with the anionic exchanger but still lacked the resolving power for certain hemoglobins. Also, the time to elute all hemoglobin fractions was relatively long, being 90 minutes. Ou and colleagues have reported a high-performance liquid chromatographic technic that uses a poly-aspartic acid linked to silica as a packing material. This weak cation exchange packing material provides for a significant improvement in resolution and sensitivity and a reduction in their chromatographic time to 30 minutes. 7 We present here a brief description of the method and three cases from our laboratory to illustrate the power of HPLC for hemoglobin study.
Methods
High-performance liquid chromatography was performed by the method of Ou and colleagues, as previously described. 7 In brief, hemolysate was injected into a column packed with a weak cation exchanger prepared by coating silica with poly-aspartic acid (Poly CAT A, Custom LC, Houston, TX). The chromatographic separation was achieved using gradient elution. Mobile phase A contained 40 mM Bis-TRIS and 4 mM KCN (pH 6.5). Mobile phase B contained 40 mM Bis-TRIS, 4 mM KCN and 0.2 M NaCl (pH 6.8). Using a flow rate of 1 mL/minute, the column was equilibrated with mobile phase of 22% B, 78% A. Phase B was increased linearly to 56% and 100% at 16 and 22 minutes, respectively, and then decreased to 22% at 24 minutes. The effluent was monitored at 436 nm, and peak areas were used for quantitation. Hemoglobin electrophoresis was done on cellulose acetate and citrate agar using standard methods. 8 Cellulose acetate membranes were scanned using the Beckman Microzone Densitometer® (Model R-110). Hemoglobin A 2 was quantitated using DEAE-cellulose micro-columns (Isolab, Akron, OH) according to the method of Abraham and co-workers as modified by Huisman and colleagues. 4 
Report of Three Cases
HbA 2 = 2.6% (Fig. \A) . As in case 1, the HbA region was indistinct. On examination of the peripheral smear, no sickled cells were seen. HPLC quantitation (Fig. 3B) showed HbA = 3.6%, HbF = 50.2%, HbS = 43.4%, and HbA 2 = 2.8%. A diagnosis of S/|S + thalassemia was made. The immediate family was studied (Table 1 and Fig. I A) with quantitation of hemoglobin fractions by cellulose acetate, HPLC, and, when appropriate, Hb A 2 by low-pressure ion exchange column chromatography. Because of the unusually high HbF in the mother, a KJeihauer-Betke stain was performed and showed a heterogeneous pattern. On the basis of an elevated HbF with a heterogeneous pattern and an elevated HbA 2 , the mother appears to have /3 + thalassemia trait with high HbF (a rare variant of fi + thalassemia) rather than jS + thalassemia trait and hereditary persistence of HbF. 9 The father was diagnosed as having sickle cell trait.
Case 1
This five-month-old black female was born to a mother with previously diagnosed sickle cell trait. At three months of age, the child was diagnosed as "probable sickle cell disease" on the basis of results from the State Laboratory newborn screening program. The results of cellulose acetate and acid citrate electrophoreses were HbF = 76%, HbS = 24%. The patient was admitted to the hospital at five months of age with otitis. She had a hemoglobin level of 11.1 g/dL, and no sickled cells were seen on the peripheral smear. Because there was a lack of symptoms or signs compatible with sickle cell disease, a hemoglobin electrophoresis was requested. Hemoglobin analysis by cellulose acetate electrophoresis (Fig.  \A) showed HbA = 0%, HbF = 50.3%, HbS = 47.1%, and HbA 2 = 2.6%. The HbA region was indistinct due to overlap by HbF, so that no definite band was seen. Hemoglobin analysis by HPLC (Figs. 2 and 3^4) showed HbA = 8.8%, HbF = 41.7%, HbS = 44.5%, HbA 2 = 5.0%. Based on these data, a diagnosis of S//3 + thalassemia was made.
Case 2
The patient was a two-year-old black female in good health who was referred for hemoglobin electrophoresis as part of a family study. Her two and a half-month-old brother was found to have only HbF and HbS on a newborn screen done by the State Laboratory at one week of age. A hemoglobin analysis of the patient's blood specimen by cellulose acetate electrophoresis showed HbA = 0%, HbF = 54.8%, HbS = 42.6%, and ROGERS ET AL.
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Although the HPLC method did not detect any HbA in the two and a half-month-old sibling, a diagnosis of S//T thalassemia was made based on the family study.
Case 3
The patient was a seven-year-old black female who was brought to the emergency room unresponsive and in asystole. Her hemoglobin level was 2.4 g/dL. Resuscitation attempts, including 2 units of O-negative blood, failed. The child's history was significant for repair of an atrial septal defect at age three years, as well as a vague "blood disease." Blood cultures taken at the time of admission grew Streptococcus pneumoniae. The patient died shortly thereafter. The autopsy findings, including acutely hemorrhagic adrenals, were consistent with sepsis. Irreversibly sickled cells were apparent in the histologic sections of the spleen. Hemoglobin electrophoresis on cellulose acetate was performed on posttransfusional blood obtained at autopsy, and the values were HbA = 89.2%, HbS = 3.7%, and 7.1% of the total hemoglobin in the HbA 2 region (Fig. \A) . Hemoglobin C was not detectable by citrate agar electrophoresis (Fig. IB) . Analysis by HPLC showed the following results: HbA = 81.8%, HbF = 3.1%, HbS = 4.2%, HbA 2 = 2.6%, HbC = 3.4% (Fig. 2) . From this data, Hb SC disease with recent transfusion was diagnosed. Old records were obtained, and it was documented that Hb SC disease was diagnosed four years previously by routine methods.
Discussion
The high-performance liquid chromatographic technic described here can easily be used in the reference and routine clinical laboratory for evaluation of hemoglobinopathies and thalassemia. The procedure is fast (30 minutes per sample), sensitive, and precise. The excellent resolving power of this column has been demonstrated previously). 7 The three cases presented emphasize the value of the increased sensitivity achieved by this technic. Cases 1 and 2 demonstrate the ability to detect HbA when routine methods fail. In the absence of family studies (case 1), this can be important.
Because of its marked sensitivity, HPLC would be useful as a confirmatory test of sickle cell anemia in newborn screening programs. False positive diagnoses of sickle cell anemia are unavoidable in newborn screening programs using routine electrophoretic methods of hemoglobin analysis. 3 Emphasized by cases 1 and 2, HPLC can detect very small quantities of HbA in the S//3 + thalassemia double heterozygote, who, without Hb A, would be given the diagnosis of sickle cell anemia.
However, HPLC does have limitations, as demonstrated by Case 2. This family appears to have a rare variant of /3 + -thalassemia, with exceptionally low levels of Hb A in the double heterozygote S//3 + thalassemia. In the two and a half-month-old sibling, this HPLC technic was unable to detect HbA. We would predict that, by HPLC, HbA will be detectable in this child as he ages, as it was in the two-year-old sibling. Case 3 illustrates the increased sensitivity of HPLC in the diagnosis of hemoglobinopathy in a transfused patient. HbC was not seen on citrate agar electrophoresis, but was easily detectable by HPLC. All of these cases demonstrate the effectiveness of HPLC to detect small quantities of hemoglobin fractions not seen by routine methods and highlight its usefulness to diagnose hemoglobinopathies and thalassemia.
